Targeting PI3K for anti-leukemias:A model study on HL-60 human cell lines

来源 :第十一届全国化学生物学学术会议 | 被引量 : 0次 | 上传用户:jijididixia
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  HL-60 cell line was originated from a female patient with acute promyelocytic leukemia(APL),whose features have made itself an interesting and useful model for the studies of human myeloid cell differentiation.
其他文献
As a part of our ongoing effort in establishing the bis-lactam [i,i+4]-stapling as an efficacious peptide stapling mode that can be employed for biomedical applications,like the bis-lactam peptide [i,
酪氨酸蛋白激酶在肿瘤的发生、增殖、恶化过程中都起着重要的作用。截止2017 年,FDA 批准的38 种小分子蛋白激酶抑制剂中,酪氨酸蛋白激酶抑制剂占29 种。因此,以酪氨酸蛋白激酶为靶点进行抗肿瘤药物设计已经成为目前研究的热点。
The Stp1 phosphatase represents a novel target for antivirulence of S.aureus.[1] How Stp1 recognizes the phosphorylated peptide remains unclear,however.
Selective protein labeling in live cells has been crucial for molecular biology studies[1-3].However,due to the highly complicated environment in live cells with coexistence of thousands of proteins,i
Our study here aimed to investigate the mechanism and target for how andrographolide protects neurons in Parkinsons disease.Andrographolide administration improved behavioural deficits and attenuated
由于肿瘤具有不同于正常细胞的代谢特征,因此针对肿瘤代谢的关键蛋白进行定向的小分子干预,能在不影响正常细胞的情况下产生抗癌效果[1],是一种新的药物治疗策略。我们新近发现芸香科植物Rutaecae(Bouchardatia neurococca)中提取的天然降脂分子Bouchardatine(Bou)[2-3]可通过激活HCT116 细胞系中的SIRT1-PGC-1α-UCP2 通路,上调解偶联蛋白
Alkali-insoluble(1→3)-β-D-glucan was extracted from yeast cell wall by acid-base method.It was found that the purity of the sample was greatly improved after the precipitation was treated by alkali at
Cisplatin and oxaliplatin are widely used chemotherapeutic agents with different anti-tumor spectra.[1] Cisplatin is believed to covalently bind DNA nucleobases,and such Pt-DNA adducts cause replicati
Arsenic trioxide(As2O3)has been approved for the treatment of acute promyelocytic leukemia(APL); however,its use in the treatment of solid tumors is limited due to its pharmacokinetic properties.
Autophagy is a catabolic process for removing aggregated proteins and damaged organelles,of which mitochondria are one of the major targets in autophagy.